Physician profile
Wayne J Bellucci
NPI 1689856999
$9,367.05
in general payments reported to CMS, 2019-2025
36 companies · $1,597 in 2025
The $1,597 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,288 · 2020: $1,022 · 2021: $923 · 2022: $1,486 · 2023: $1,630 · 2024: $1,422 · 2025: $1,597.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,596 · Education: $52.39.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,595.79 |
| Education | $52.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,185.00 | 2019-2025 | Tezspire, Airsupra, Fasenra |
| Glaxosmithkline, LLC. | $1,753.45 | 2019-2025 | Nucala, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,161.19 | 2019-2025 | Ofev, Jascayd, Stiolto Respimat |
| Grifols USA, LLC | $592.84 | 2019-2025 | Prolastin-C Liquid |
| Genzyme Corporation | $587.54 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $511.33 | 2022-2025 | Dupixent |
| Genentech USA, INC. | $381.72 | 2019-2020 | |
| Electromed, INC. | $378.41 | 2021-2025 | Smartvest |
| Merck Sharp & Dohme LLC | $368.52 | 2019-2025 | Zerbaxa, Dificid, Recarbrio |
| Baxter Healthcare | $178.76 | 2022-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Metaneb System, Hillrom - Life 2000 Ventilation System |
| Philips North America LLC | $169.65 | 2019-2025 | Vest Therapy Und |
| Fisher & Paykel Healthcare INC | $126.07 | 2023 | Fisher & Paykel Healthcare |
| Amgen INC. | $120.35 | 2022-2025 | Tezspire |
| Sanofi-Aventis U.S. LLC | $81.99 | 2022 | |
| Verona Pharma, INC. | $79.81 | 2025 | Ohtuvayre |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $63.00 | 2025 | Arikayce |
| Advanced Respiratory, INC | $62.24 | 2020-2021 | |
| Viatris Specialty LLC | $59.21 | 2025 | Yupelri |
| Exact Sciences Corporation | $57.20 | 2023-2024 | Cologuard Collection Kit |
| Teva Pharmaceuticals USA, INC. | $54.83 | 2022 | |
| Lilly USA, LLC | $50.18 | 2025 | Zepbound |
| Mylan Specialty L.P. | $48.31 | 2019-2021 | |
| Inspire Medical Systems, INC. | $31.84 | 2023 | Inspire |
| Novo Nordisk INC | $31.31 | 2025 | |
| Boston Scientific Corporation | $26.68 | 2023 | Varithena Administration Pack |
| Gilead Sciences, INC. | $24.28 | 2021 | |
| Novartis Pharmaceuticals Corporation | $23.77 | 2022 | |
| Abbvie INC. | $21.11 | 2023 | Teflaro |
| Vapotherm INC | $20.05 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.39 | 2023 | Hyqvia |
| Astellas Pharma US INC | $18.36 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.08 | 2019 | |
| Circassia INC. | $16.97 | 2019 | |
| Chiesi USA, INC. | $16.75 | 2024 | Cleviprex |
| Janssen Pharmaceuticals, INC | $14.33 | 2021 | |
| Allergan, INC. | $12.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Bellucci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.